<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365428">
  <stage>Registered</stage>
  <submitdate>5/12/2013</submitdate>
  <approvaldate>12/12/2013</approvaldate>
  <actrnumber>ACTRN12613001360707</actrnumber>
  <trial_identification>
    <studytitle>The effect of perioperative intra-articular magnesium on postoperative pain after shoulder surgery</studytitle>
    <scientifictitle>Is perioperative intraarticular magnesium effective for postoperative analgesia in arthroscopic shoulder surgery?</scientifictitle>
    <utrn> U1111-1151-0572</utrn>
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>ASA 1-2 patients scheduled for arthroscopic shoulder surgery by the Orthopaedics Department.</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Group M (Magnesium): Patients (n=30) had 1000 mg  magnesium sulphate  (100 mg ml-1)intraarticular in 10 ml saline

Magnesium administered after completion of the surgery before extubation intraarticularly over 5 minutes.</interventions>
    <comparator>Group C (Control): Patients (n=30) had 10 ml saline administered intraarticularly over 5 minutes after completion of the surgery and before extubation</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Postoperative pain reduction. Pain assessment done with visual analogue scale.</outcome>
      <timepoint>At postoperative 24 hours.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome> If any decrement present in total diclofenac consumption (It is allowed 2 times diclofenac injection if patient wants) and intraarticular morphine + bupivacaine consumption (with patient controlled analgesia device) in magnesium group when compared to control group.

Diclofenac amount recorded at study protocol paper. Morphine bupivacaine amount recorded study protocol paper by looking at the PCA device. </outcome>
      <timepoint>At the end of postoperative 24 hours</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Shoulder pain assessment with visuel analogue scale.</outcome>
      <timepoint>At 1,2,6,8,12,18,24 hours after the operation. </timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>The inclusion criteria were participants are  scheduled for arthroscopic shoulder surgery who not to have  had any analgesic or corticosteroid for preceeding 72 hours, not to have any drug or alcohol addiction, not to be allergic to study drugs, and be able to use patient controlled analgesia </inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Exclusion criteria included; known allergy to one of the study drugs; major hepatic, renal, or cardiovascular dysfunction, especially atrioventricular block; and prior treatment with opioids and calcium channel blockers.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelopes</concealment>
    <sequence>Computer based randomisation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods>Sample size was estimated using pain scores as the primary variable. It was calculated a group size of 30 patients would be sufficient to detect a difference of 1 cm on the VAS.  It was assumed a SD of 1 cm. and at an alpha threshold of 0.007 with 90% power. </statisticalmethods>
    <masking1>False</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>False</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>30/11/2009</anticipatedstartdate>
    <actualstartdate>30/11/2009</actualstartdate>
    <anticipatedenddate>15/10/2010</anticipatedenddate>
    <actualenddate>16/07/2010</actualenddate>
    <samplesize>70</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>KONYA</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Meram Medical School</primarysponsorname>
    <primarysponsoraddress>Meram Medical School Akyokus Street  42080 Meram Konya</primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Meram Medical School</fundingname>
      <fundingaddress>Meram Medical School Akyokus Street  42080 Meram Konya</fundingaddress>
      <fundingcountry>Turkey</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Magnesium has analgesic properties, primarily related to the antagonism of the N-methyl-o-aspartate (NMDA) receptor  and the regulation of calcium influx into cells . This analgesic effect was first demonstrated in humans in 1996 when magnesium was administered intravenously in the peri-operative period . It has been reported to reduce postoperative analgesic requirements .  
The analgesic efficacy of intraarticular magnesium is evident after knee surgery, but its effect after shoulder surgeries has not been reported in the literature . Thus, the goal of this study is to evaluate the potential analgesic effect of magnesium when injected intraarticularly during arthroscopic shoulder surgery.
</summary>
    <trialwebsite />
    <publication>This trial preliminary report was presented at VI. International Congress Orthopaedic Anaesthesia and Pain</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Meram Medical School Ethics Committee</ethicname>
      <ethicaddress>Meram Medical School Akyokus Street  42080 Meram Konya</ethicaddress>
      <ethicapprovaldate>29/05/2009</ethicapprovaldate>
      <hrec>2009-249</hrec>
      <ethicsubmitdate>15/05/2009</ethicsubmitdate>
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Tuba Berra Saritas</name>
      <address>Meram Medical School Anesthesiology DPT Akyokus Street  42080 Meram Konya</address>
      <phone>+905443664244</phone>
      <fax />
      <email>tsaritas@konya.edu.tr</email>
      <country>Turkey</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Tuba Berra Saritas</name>
      <address>Meram Medical School Anesthesiology DPT Akyokus Street  42080 Meram Konya</address>
      <phone>+905443664244</phone>
      <fax />
      <email>tsaritas@konya.edu.tr</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Tuba Berra Saritas</name>
      <address>Meram Medical School Anesthesiology DPT Akyokus Street  42080 Meram Konya</address>
      <phone>+905443664244</phone>
      <fax />
      <email>tsaritas@konya.edu.tr</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Tuba Berra Saritas</name>
      <address>Meram Medical School Anesthesiology DPT Akyokus Street  42080 Meram Konya</address>
      <phone>+905443664244</phone>
      <fax />
      <email>tsaritas@konya.edu.tr</email>
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>